Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatment

Baljevic, M., Gasparetto, C., Schiller, G. J., Tuchman, S. A., Callander, N. S., Lentzsch, S., Monge, J., Kotb, R., Bahlis, N. J., White, D., Chen, C. I., Sutherland, H. J., Madan, S., LeBlanc, R., Sebag, M., Venner, C. P., Bensinger, W. I., Biran, N., DeCastro, A., … Lipe, B. (2022). Selinexor‐based regimens in patients with multiple myeloma after prior anti‐B‐cell maturation antigen treatment. EJHaem, 3(4), 1270–1276. Portico. https://doi.org/10.1002/jha2.572
Authors:
Muhamed Baljevic
Cristina Gasparetto
Gary J Schiller
Sascha A Tuchman
Natalie S Callander
Suzanne Lentzsch
Jorge Monge
Rami Kotb
Nizar J Bahlis
Darrell White
Christine I Chen
Heather J Sutherland
Sumit Madan
Richard LeBlanc
Michael Sebag
Christopher P Venner
William I Bensinger
Noa Biran
Andrew DeCastro
Dane R Van Domelen
Chris Zhang
Jatin J Shah
Sharon Shacham
Michael G Kauffman
Ohad S Bentur
Brea Lipe
Affiliated Authors:
Suzanne Lentzsch
Author Keywords:
anti-bcma
multiple myeloma
selinexor
anti‐bcma
Publication Type:
Article
Unique ID:
10.1002/jha2.572
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: